Research Status of SARS-CoV-2 Omicron Variant-infected Pregnant Women
10.13471/j.cnki.j.sun.yat-sen.univ（med.sci）.20230129.001
- VernacularTitle:孕产妇感染新型冠状病毒Omicron变异株的研究现状
- Author:
Qian GAO
1
;
Cheng-fang XU
1
Author Information
1. Department of Obstetrics and Gynecology，The Third Affiliated Hospital of Sun Yat-sen University，Guangzhou 510630
- Publication Type:Review
- Keywords:
SARS-CoV-2;
Omicron;
pregnancy;
clinical manifestation;
treatment
- From:
Journal of Sun Yat-sen University(Medical Sciences)
2023;44(2):209-216
- CountryChina
- Language:Chinese
-
Abstract:
The new variant B.1.1.529 of COVID-19 was reported to the WHO for the first time by South Africa on November 24， 2021. At present， Omicron has become the dominant strain in the world and is spreading rapidly. Although Omicron infected during pregnancy shows the lower risk of serious maternal and fetal complications than the previous variants and Delta variant， the rapid increase in the number of cases and the wide range of patients still worth attention of obstetricians. This article reviews the prevalence of Omicron variant infection， the clinical characteristics ， the prevention and the treatment of pregnant women infected with Omicron， as well as the breastfeeding of newborns. It is believed that Omicron infection will not increase the rate of early spontaneous abortion and the infant congenital malformations， but it may increase the risk of gestational hypertensive disorders， premature delivery， cesarean section， and postpartum hemorrhage in the third trimester of pregnancy.We put forward corresponding management strategies and suggestions to provide references for the diagnosis and treatment of novel coronavirus infection in pregnant women in China.
